Application of novel 3D-bioprinted human liver tissue models in drug discovery research
Primary human hepatocytes are widely used to study drug metabolism and enzyme induction. However, primary hepatocytes rapidly lose their hepatic function in conventional 2D cultures. Recently, a microphysiological system that overcomes this drawback has been actively investigated and applied in drug...
Gespeichert in:
| Veröffentlicht in: | Folia Pharmacologica Japonica 2019, Vol.153(6), pp.284-288 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng ; jpn |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 288 |
|---|---|
| container_issue | 6 |
| container_start_page | 284 |
| container_title | Folia Pharmacologica Japonica |
| container_volume | 153 |
| creator | Ohbuchi, Masato |
| description | Primary human hepatocytes are widely used to study drug metabolism and enzyme induction. However, primary hepatocytes rapidly lose their hepatic function in conventional 2D cultures. Recently, a microphysiological system that overcomes this drawback has been actively investigated and applied in drug discovery research. Such novel in vitro models are desirable for the evaluation of the metabolic clearance of drugs with low turnover, drug-induced liver injury, and chronic liver diseases like liver fibrosis. This article reviews the characteristics and recent advances in 3D-bioprinted human liver tissue models in drug discovery research. |
| doi_str_mv | 10.1254/fpj.153.284 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2273224324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2273224324</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2554-bca59aed83784ef530577af10191399c370ed0370b5fc4cc63eb569a47e3e1243</originalsourceid><addsrcrecordid>eNo9kD1PwzAQhi0EolXpxI48IqEUO7bjZEJV-ZQqsYAYLce5tK7yhZ1U6r_H0JLlbrjnXt09CF1TsqCx4Pdlt1tQwRZxys_QlDIuo5Rl8hxNCaEiEklGJ2juvc0JETKWCaOXaMIolalgfIq-ll1XWaN72za4LXHT7qHC7DHKbds52_RQ4O1Q6wZXdg8O99b7AXDdFlB5bBtcuGGDC-tNWHQH7MCDdmZ7hS5KXXmYn_oMfT4_faxeo_X7y9tquY5MLASPcqNFpqFImUw5lIKFI6UuKaEZZVlmmCRQkFBzURpuTMIgDz9pLoEBjTmbodtjbufa7wF8r-pwC1SVbqAdvIpjyeLA_aF3R9S41nsHpQoP1todFCXqV6YKMlWQqYLMQN-cgoe8hmJk_9UF4OEI7HyvNzAC2vXWVDCGJf-R48RstVPQsB--_YZR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2273224324</pqid></control><display><type>article</type><title>Application of novel 3D-bioprinted human liver tissue models in drug discovery research</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ohbuchi, Masato</creator><creatorcontrib>Ohbuchi, Masato</creatorcontrib><description>Primary human hepatocytes are widely used to study drug metabolism and enzyme induction. However, primary hepatocytes rapidly lose their hepatic function in conventional 2D cultures. Recently, a microphysiological system that overcomes this drawback has been actively investigated and applied in drug discovery research. Such novel in vitro models are desirable for the evaluation of the metabolic clearance of drugs with low turnover, drug-induced liver injury, and chronic liver diseases like liver fibrosis. This article reviews the characteristics and recent advances in 3D-bioprinted human liver tissue models in drug discovery research.</description><identifier>ISSN: 0015-5691</identifier><identifier>EISSN: 1347-8397</identifier><identifier>DOI: 10.1254/fpj.153.284</identifier><identifier>PMID: 31178534</identifier><language>eng ; jpn</language><publisher>Japan: The Japanese Pharmacological Society</publisher><ispartof>Folia Pharmacologica Japonica, 2019, Vol.153(6), pp.284-288</ispartof><rights>2019 by The Japanese Pharmacological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2554-bca59aed83784ef530577af10191399c370ed0370b5fc4cc63eb569a47e3e1243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31178534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohbuchi, Masato</creatorcontrib><title>Application of novel 3D-bioprinted human liver tissue models in drug discovery research</title><title>Folia Pharmacologica Japonica</title><addtitle>Nihon Yakurigaku Zasshi</addtitle><description>Primary human hepatocytes are widely used to study drug metabolism and enzyme induction. However, primary hepatocytes rapidly lose their hepatic function in conventional 2D cultures. Recently, a microphysiological system that overcomes this drawback has been actively investigated and applied in drug discovery research. Such novel in vitro models are desirable for the evaluation of the metabolic clearance of drugs with low turnover, drug-induced liver injury, and chronic liver diseases like liver fibrosis. This article reviews the characteristics and recent advances in 3D-bioprinted human liver tissue models in drug discovery research.</description><issn>0015-5691</issn><issn>1347-8397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kD1PwzAQhi0EolXpxI48IqEUO7bjZEJV-ZQqsYAYLce5tK7yhZ1U6r_H0JLlbrjnXt09CF1TsqCx4Pdlt1tQwRZxys_QlDIuo5Rl8hxNCaEiEklGJ2juvc0JETKWCaOXaMIolalgfIq-ll1XWaN72za4LXHT7qHC7DHKbds52_RQ4O1Q6wZXdg8O99b7AXDdFlB5bBtcuGGDC-tNWHQH7MCDdmZ7hS5KXXmYn_oMfT4_faxeo_X7y9tquY5MLASPcqNFpqFImUw5lIKFI6UuKaEZZVlmmCRQkFBzURpuTMIgDz9pLoEBjTmbodtjbufa7wF8r-pwC1SVbqAdvIpjyeLA_aF3R9S41nsHpQoP1todFCXqV6YKMlWQqYLMQN-cgoe8hmJk_9UF4OEI7HyvNzAC2vXWVDCGJf-R48RstVPQsB--_YZR</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Ohbuchi, Masato</creator><general>The Japanese Pharmacological Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2019</creationdate><title>Application of novel 3D-bioprinted human liver tissue models in drug discovery research</title><author>Ohbuchi, Masato</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2554-bca59aed83784ef530577af10191399c370ed0370b5fc4cc63eb569a47e3e1243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohbuchi, Masato</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Folia Pharmacologica Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohbuchi, Masato</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of novel 3D-bioprinted human liver tissue models in drug discovery research</atitle><jtitle>Folia Pharmacologica Japonica</jtitle><addtitle>Nihon Yakurigaku Zasshi</addtitle><date>2019</date><risdate>2019</risdate><volume>153</volume><issue>6</issue><spage>284</spage><epage>288</epage><pages>284-288</pages><issn>0015-5691</issn><eissn>1347-8397</eissn><abstract>Primary human hepatocytes are widely used to study drug metabolism and enzyme induction. However, primary hepatocytes rapidly lose their hepatic function in conventional 2D cultures. Recently, a microphysiological system that overcomes this drawback has been actively investigated and applied in drug discovery research. Such novel in vitro models are desirable for the evaluation of the metabolic clearance of drugs with low turnover, drug-induced liver injury, and chronic liver diseases like liver fibrosis. This article reviews the characteristics and recent advances in 3D-bioprinted human liver tissue models in drug discovery research.</abstract><cop>Japan</cop><pub>The Japanese Pharmacological Society</pub><pmid>31178534</pmid><doi>10.1254/fpj.153.284</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0015-5691 |
| ispartof | Folia Pharmacologica Japonica, 2019, Vol.153(6), pp.284-288 |
| issn | 0015-5691 1347-8397 |
| language | eng ; jpn |
| recordid | cdi_proquest_miscellaneous_2273224324 |
| source | EZB-FREE-00999 freely available EZB journals |
| title | Application of novel 3D-bioprinted human liver tissue models in drug discovery research |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A46%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20novel%203D-bioprinted%20human%20liver%20tissue%20models%20in%20drug%20discovery%20research&rft.jtitle=Folia%20Pharmacologica%20Japonica&rft.au=Ohbuchi,%20Masato&rft.date=2019&rft.volume=153&rft.issue=6&rft.spage=284&rft.epage=288&rft.pages=284-288&rft.issn=0015-5691&rft.eissn=1347-8397&rft_id=info:doi/10.1254/fpj.153.284&rft_dat=%3Cproquest_cross%3E2273224324%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2273224324&rft_id=info:pmid/31178534&rfr_iscdi=true |